Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2.
Cui Y, Wang R, Wei Y, Hou F, Li H, Jiang Y, Sun Y, Fu S, Zuo L, Wang X, Li M, Li J, Liu N, Zhang K, Wei M, Yang G.
Cui Y, et al. Among authors: fu s.
Bioorg Med Chem. 2023 Mar 1;81:117202. doi: 10.1016/j.bmc.2023.117202. Epub 2023 Feb 11.
Bioorg Med Chem. 2023.
PMID: 36804726